• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

370
60
44
42
20

COUNTRY

41
9
5
5
4

PRICE

136
413
509
1,026

PUBLISHED

16
60
287
1,026

PRODUCT TYPE

993
17
11
4
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

2013 U.S. Management of companies and enterprises commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Management of companies and enterprises commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

2013 U.S. Employment services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Employment services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics, forecasts...

May 2013
FROM

Neuropsychology and Philosophy of Mind in Process

Aims and Scope: This volume celebrates the life achievements of Jason W Brown, who, along with Jean Piaget, Heinz Werner, Alexander Luria and the Würzburg school, has significantly contributed to the...

May 2013
FROM

Cancer Pain Global Clinical Trials Review, H1, 2013

Cancer Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario....

April 2013
FROM

Inflammatory Pain Global Clinical Trials Review, H1, 2013

Inflammatory Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2013" provides data on the Inflammatory Pain clinical...

April 2013
FROM

Tension -Type Headache Global Clinical Trials Review, H1, 2013

Tension -Type Headache Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2013" provides data on the Tension -Type...

April 2013
FROM
Essential Tremor - Pipeline Review, H1 2013 Essential Tremor - Pipeline Review, H1 2013 - Product Thumbnail Image

Essential Tremor - Pipeline Review, H1 2013

Essential Tremor – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Essential Tremor - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Neuropathy - Pipeline Review, H1 2013 Neuropathy - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuropathy - Pipeline Review, H1 2013

Neuropathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuropathy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Sedation - Pipeline Review, H1 2013 Sedation - Pipeline Review, H1 2013 - Product Thumbnail Image

Sedation - Pipeline Review, H1 2013

Sedation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sedation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Motor Neurone Diseases - Pipeline Review, H1 2013 Motor Neurone Diseases - Pipeline Review, H1 2013 - Product Thumbnail Image

Motor Neurone Diseases - Pipeline Review, H1 2013

Motor Neurone Diseases – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Motor Neurone Diseases - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Muscle Spasticity - Pipeline Review, H1 2013 Muscle Spasticity - Pipeline Review, H1 2013 - Product Thumbnail Image

Muscle Spasticity - Pipeline Review, H1 2013

Muscle Spasticity – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Spasticity - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Cerebral Palsy - Pipeline Review, H1 2013 Cerebral Palsy - Pipeline Review, H1 2013 - Product Thumbnail Image

Cerebral Palsy - Pipeline Review, H1 2013

Cerebral Palsy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cerebral Palsy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013 Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013 - Product Thumbnail Image

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013

Relapsing Multiple Sclerosis (RMS) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2013', provides an overview of the indication’s...

April 2013
FROM
Disruptive Behavior Disorder - Pipeline Review, H1 2013 Disruptive Behavior Disorder - Pipeline Review, H1 2013 - Product Thumbnail Image

Disruptive Behavior Disorder - Pipeline Review, H1 2013

Disruptive Behavior Disorder – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Disruptive Behavior Disorder - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Acute Spinal Cord Injury - Pipeline Review, H1 2013 Acute Spinal Cord Injury - Pipeline Review, H1 2013 - Product Thumbnail Image

Acute Spinal Cord Injury - Pipeline Review, H1 2013

Acute Spinal Cord Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Spinal Cord Injury - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Paralysis - Pipeline Review, H1 2013 Paralysis - Pipeline Review, H1 2013 - Product Thumbnail Image

Paralysis - Pipeline Review, H1 2013

Paralysis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Paralysis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM

Post-Operative Pain Global Clinical Trials Review, H1, 2013

Post-Operative Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H1, 2013" provides data on the Post-Operative Pain...

April 2013
FROM

Osteoarthritis Pain Global Clinical Trials Review, H1, 2013

Osteoarthritis Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H1, 2013" provides data on the Osteoarthritis Pain...

April 2013
FROM

Joint Pain Global Clinical Trials Review, H1, 2013

Joint Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Joint Pain Global Clinical Trials Review, H1, 2013" provides data on the Joint Pain clinical trial scenario This...

April 2013
FROM

Complex Regional Pain Syndrome Global Clinical Trials Review, H1, 2013

Complex Regional Pain Syndrome Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, H1, 2013" provides data on the...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos